BlackRock Inc. purchased a new position in shares of The Oncology Institute, Inc. (NASDAQ: TOI) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 4,749,030 shares of the company's stock, valued at approximately $25,787,000. BlackRock Inc. owned approximately 4.80% of Oncology Institute